Heidelberg Pharma AG (ETR:HPHA)

PRESS RELEASE

published on 03/06/2024 at 07:46, 2 years 4 months ago

Heidelberg Pharma to Present First Efficacy Data on HDP-101 and Data from Proprietary ADC Technology Platform at AACR Meeting 2024
Heidelberg Pharma to present first efficacy data on HDP-101 and data from proprietary ADC technology platform at AACR Meeting 2024. Details of ATAC and ADC-based cancer therapies

Clinical Trials Heidelberg Pharma ADC Technology AACR Meeting 2024 ATAC Therapies
BRIEF

published on 03/04/2024 at 11:24, 2 years 4 months ago

Heidelberg Pharma Secures Up to $115 Million in Royalty Financing from HealthCare Royalty

Biopharmaceuticals Heidelberg Pharma HealthCare Royalty Royalty Financing ZircaixTM
BRIEF

published on 03/04/2024 at 11:24, 2 years 4 months ago

Heidelberg Pharma obtient jusqu'à 115 millions de dollars de financement en redevances auprès de HealthCare Royalty

Heidelberg Pharma Redevance En Matière De Soins De Santé Financement Des Redevances ZircaixTM Produits Biopharmaceutiques
PRESS RELEASE

published on 03/04/2024 at 11:19, 2 years 4 months ago

Heidelberg Pharma Announces Royalty Financing Agreement with HealthCare Royalty for up to USD 115 million
Heidelberg Pharma announces royalty financing agreement with HealthCare Royalty for up to USD 115 million. Agreement to purchase royalties from Telix Pharmaceuticals for Zircaix(TM)

Biotech Heidelberg Pharma HealthCare Royalty Royalty Financing Zircaix
BRIEF

published on 03/04/2024 at 11:07, 2 years 4 months ago

Heidelberg Pharma Secures Royalty Financing Deal Worth Up to $115 Million with HealthCare Royalty

Oncology Heidelberg Pharma HealthCare Royalty Royalty Financing Zircaix
BRIEF

published on 03/04/2024 at 11:07, 2 years 4 months ago

Heidelberg Pharma conclut un accord de financement de redevances d'une valeur pouvant atteindre 115 millions de dollars avec HealthCare Royalty

Oncologie Heidelberg Pharma Zircaix Redevance En Matière De Soins De Santé Financement Des Redevances
PRESS RELEASE

published on 03/04/2024 at 11:02, 2 years 4 months ago

EQS-Adhoc: Heidelberg Pharma Announces Royalty Financing Agreement with HealthCare Royalty for up to USD 115 million
Heidelberg Pharma announces royalty financing agreement with HealthCare Royalty for up to USD 115 million. Agreement involves royalties from worldwide sales of Telix Pharmaceuticals' ZircaixTM

Heidelberg Pharma HealthCare Royalty Royalty Financing Telix Pharmaceuticals ZircaixTM
PRESS RELEASE

published on 11/02/2023 at 16:34, 2 years 8 months ago

Heidelberg Pharma Presents New Clinical Data from its Lead Candidate HDP-101 at the ASH Annual Meeting 2023
PRESS RELEASE

published on 10/12/2023 at 07:09, 2 years 9 months ago

Heidelberg Pharma AG: Interim Management Statement on the First Nine Months of 2023
PRESS RELEASE

published on 09/19/2023 at 07:11, 2 years 9 months ago

Heidelberg Pharma AG: Heidelberg Pharma Provides Update on Phase I/IIa Clinical Trial with Lead Candidate HDP-101

Published on 07/14/2026 at 01:45, 4 hours 16 minutes ago

Arctic Fox Lithium Approved for Trading on the OTCQB Venture Market and Announces DTC Eligibility
Published on 07/14/2026 at 00:01, 6 hours ago

Captor Capital Announces Delay in its Annual Filings
Published on 07/13/2026 at 23:10, 6 hours 51 minutes ago

Galaxy Ventures Inc. Announces Director Resignation
Published on 07/13/2026 at 21:35, 8 hours 26 minutes ago

ATHA Energy Announces Corporate Activities Update
Published on 07/13/2026 at 20:00, 10 hours 1 minute ago

IBC Announces Share-Based Compensation to Directors

View all ACCESSWIRE

Published on 07/14/2026 at 04:45, 1 hour 16 minutes ago

Asia’s Debut of LEAP East in HKCEC Marks Hong Kong’s Largest Inaugural Tech Summit
Published on 07/13/2026 at 22:30, 7 hours 31 minutes ago

Half-year 2026 Results Media and Investor Conference Call and Webcast
Published on 07/13/2026 at 21:20, 8 hours 41 minutes ago

Evotec Announces Preliminary Second Quarter and First Half 2026 Results and Updates Full-Year 2026 Outlook
Published on 07/13/2026 at 21:17, 8 hours 43 minutes ago

EQS-Adhoc: Ad hoc: Evotec Announces Preliminary Second Quarter and First Half 2026 Results and Updates Full-Year 2026 Outlook
Published on 07/13/2026 at 20:48, 9 hours 13 minutes ago

EQS-Adhoc: Gateway Real Estate AG: Forecast for the financial year 2026

View all EQS

Published on 07/13/2026 at 18:00, 12 hours 1 minute ago

CP Icade - Icade reprend 100% de la propriété de la Tour Eqho à la Défense
Published on 07/13/2026 at 18:00, 12 hours 1 minute ago

PR Icade - Icade regains full ownership of the Eqho Tower in La Défense
Published on 07/13/2026 at 18:00, 12 hours 1 minute ago

THERMADOR GROUPE : 2026 half-year turnover
Published on 07/13/2026 at 18:00, 12 hours 1 minute ago

THERMADOR GROUPE : publication du chiffre d'affaires semestriel 2026
Published on 07/13/2026 at 17:45, 12 hours 16 minutes ago

Weekly share buyback

View all LES ECHOS COMFI WIRE

News